The Urea Transporter SLC14: Crucial for Urea Transport and Cell Biology
The Urea Transporter SLC14: Crucial for Urea Transport and Cell Biology
The urea transporter (nonspecified subtype) (SLC14) is a protein that plays a crucial role in the transport of urea across cell membranes. It is a member of the solute carrier family 14 (SLC14) and is expressed in a variety of tissues and cells throughout the body. One of its main functions is to transport urea across the endoplasmic reticulum (ER) and into the cytoplasm, where it can be used by cells for various purposes, such as energy production and DNA synthesis.
SLC14 is a transmembrane protein, which means that it spans the entire cell membrane and is involved in the production of a protein that is both extracellular and intracellular. It is made up of 14 subunits that are held together by disulfide bonds. These subunits form a monolayer and span the entire cell membrane.
SLC14 plays a critical role in the transport of urea across the ER. It is known to be involved in the delivery of urea to the cytoplasm, where it can be used by cells for various purposes. For example, urea is a precursor of nucleotides, which are the building blocks of DNA and RNA. In the cytoplasm, urea can be used to synthesize nucleotides, which can then be used for DNA replication and gene expression.
In addition to its role in urea transport, SLC14 is also involved in the transport of other molecules across cell membranes. For example, it is known to be involved in the transport of glucose, as well as various other organic and inorganic ions. These transport activities are important for maintaining the proper functioning of cells and are critical for maintaining the integrity of the cell membrane.
SLC14 is also a potential drug target in the treatment of various diseases. For example, it is known to be involved in the transport of urea to the cytoplasm in the treatment of urinary tract infections (UTIs) and urinary retention. UTIs are often caused by the bacteria that cause bacterial infections, and these infections can cause significant discomfort and inconvenience for patients. By targeting SLC14 and its role in urea transport, researchers may be able to develop new treatments for UTIs that are more effective and less invasive than current treatments.
SLC14 is also a potential biomarker for certain diseases. For example, it is known to be involved in the transport of urea to the cytoplasm in the treatment of hypoxic-ischemic brain injury (HIB), which is a condition that can occur after a period of oxygen deprivation or ischemia. HIB can cause a range of serious brain injuries, including severe cognitive impairments and even death. By targeting SLC14 and its role in urea transport, researchers may be able to develop new treatments for HIB that are more effective and less invasive than current treatments.
Overall, the urea transporter (nonspecific subtype) (SLC14) is a protein that plays a crucial role in the transport of urea across cell membranes. It is a member of the solute carrier family 14 and is expressed in a variety of tissues and cells throughout the body. Its role in urea transport is important for maintaining the proper functioning of cells, and it is also a potential drug target and biomarker for various diseases. Further research is needed to fully understand the role of SLC14 in cell biology and the development of new treatments for diseases associated with its dysfunction.
Protein Name: Urea Transporter (nonspecified Subtype)
The "Urea transporter Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Urea transporter comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
URGCP | URGCP-MRPS24 | URI1 | Uridine phosphorylase | URM1 | UROC1 | UROD | UROS | USB1 | USE1 | USF1 | USF2 | USF3 | USH1C | USH1G | USH2A | USHBP1 | USO1 | USP1 | USP1-UAF1 complex | USP10 | USP11 | USP12 | USP12-AS1 | USP12-DT | USP13 | USP14 | USP15 | USP16 | USP17L1 | USP17L10 | USP17L11 | USP17L12 | USP17L13 | USP17L14P | USP17L15 | USP17L17 | USP17L18 | USP17L2 | USP17L20 | USP17L21 | USP17L24 | USP17L25 | USP17L26 | USP17L27 | USP17L29 | USP17L3 | USP17L5 | USP17L6P | USP17L7 | USP17L8 | USP17L9P | USP18 | USP19 | USP2 | USP2-AS1 | USP20 | USP21 | USP22 | USP24 | USP25 | USP26 | USP27X | USP27X-DT | USP28 | USP29 | USP3 | USP3-AS1 | USP30 | USP30-AS1 | USP31 | USP32 | USP32P1 | USP32P2 | USP32P3 | USP33 | USP34 | USP35 | USP36 | USP37 | USP38 | USP39 | USP4 | USP40 | USP41 | USP42 | USP43 | USP44 | USP45 | USP46 | USP46-DT | USP47 | USP48 | USP49 | USP5 | USP50 | USP51 | USP53 | USP54 | USP6
